News | March 18, 2024
AstraZeneca to acquire Amolyt Pharma
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Both organisations enter into a long- term collaboration to expand patient access in India
Mungara has over 25+ years of experience in the supply chain domain
The company is confident of addressing the concern raised by the USFDA
Sen spent a decade with Biocon and held various key roles,
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Cureskin aims to disrupt the large and growing skin and hair care industry in India
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
Anand is committed to leading the company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, AI and LLM
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
